2015
DOI: 10.1111/1471-0528.13297
|View full text |Cite
|
Sign up to set email alerts
|

The Obstetric Comorbidity Index predicts severe maternal morbidity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 0 publications
0
12
0
1
Order By: Relevance
“…Despite the low sensitivity of the maternal comorbidity index to predict SMM, the c-statistic of the maternal comorbidity index was similar to the original study that developed the index (area under the curve = 0.66) 12 and the validation study (area under the curve = 0.67). 14 In addition, clinical use for the index is promising and has been validated in a prospective clinical study (c-statistic = 0.83) 13,15 ; however, the clinical study modified the comorbidity index to include conditions that have been shown to be associated with SMM, such as prepregnancy obesity and morbidly adherent placenta. The authors of the current study also agree that the maternal comorbidity index score needs to be modified to include these other comorbid conditions, including individual-level social risk factors and hospital-level factors to appropriately flag women that are at high risk for adverse birth outcomes, when used in a clinical setting.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the low sensitivity of the maternal comorbidity index to predict SMM, the c-statistic of the maternal comorbidity index was similar to the original study that developed the index (area under the curve = 0.66) 12 and the validation study (area under the curve = 0.67). 14 In addition, clinical use for the index is promising and has been validated in a prospective clinical study (c-statistic = 0.83) 13,15 ; however, the clinical study modified the comorbidity index to include conditions that have been shown to be associated with SMM, such as prepregnancy obesity and morbidly adherent placenta. The authors of the current study also agree that the maternal comorbidity index score needs to be modified to include these other comorbid conditions, including individual-level social risk factors and hospital-level factors to appropriately flag women that are at high risk for adverse birth outcomes, when used in a clinical setting.…”
Section: Discussionmentioning
confidence: 99%
“…12,13 It can also be used to track patients' burden of comorbidities across practitioners, institutions, and geographic level. 13 The maternal comorbidity index has been validated in multiple studies, including one study conducted in a hospital in Alberta, Canada, 14 and one study conducted in a single, tertiary-care, academic hospital in the United States, 15 both using clinical data linked to hospital administrative data; however, both noted that the generalizability of the index was unknown and needed to be examined. In addition, a national study examined the association between maternal comorbidity index and SMM using hospital administrative data, but they limited their sample to only low-delivery-volume (<1000) hospitals.…”
Section: Introductionmentioning
confidence: 99%
“…This score in our case was 8, which would indicate a 6.5% risk of end-organ damage or death (vs 0.7% at score 0) and 1.5% risk of maternal ICU admission (vs 0.2% at score 0) up to 30 days postpartum. The score could be used when booking pregnancies to refer patients to appropriate specialist services or tertiary care centres 10. Furthermore, the use of this score could be used as a comparative research tool 10…”
Section: Discussionmentioning
confidence: 99%
“…The Obstetric Comorbidity Index has, until now, only been validated within highly selected cohorts derived from Medicaid, a health insurance program for low‐income individuals in the USA (https://www.medicaid.gov/basic-health-program/index.html) and from one small geographic area of Canada . Validation of the index in an unselected population as well as in other health registers is, however, of high importance to determine external validity, should the Obstetric Comorbidity Index be used to inform the care of pregnant women . The Danish health registers, with complete data on all obstetric patients, due to free access to health services, are unique sources for such an assessment in a complete and unselected study population.…”
Section: Introductionmentioning
confidence: 99%
“…3,4 Validation of the index in an unselected population as well as in other health registers is, however, of high importance to determine external validity, should the Obstetric Comorbidity Index be used to inform the care of pregnant women. [5][6][7] The Danish health registers, with complete data on all obstetric patients, due to free access to health services, are unique sources for such an assessment in a complete and unselected study population.…”
Section: Introductionmentioning
confidence: 99%